Sector Update: Healthcare

By Staff,

Shutterstock photo

Health-care shares were generally higher in pre-market trade on Wednesday.

Halozyme Therapeutics ( HALO ) shares declined pre-market Wednesday, after the biopharmaceutical company said it was informed by the Food and Drug Administration that a clinical hold has been placed on patient enrollment and dosing of its PEGPH20 in an ongoing Phase 2 trial evaluating PEGPH20 in patients with pancreatic cancer.

The clinical hold comes after Halozyme last week said it was temporarily halting patient enrollment and dosing in the trial, following a recommendation.

Intuitive Surgical ( ISRG ) dropped about 9% in pre-market trading after providing disappointing preliminary guidance on Q1 results late Tuesday.

The maker of robotic surgical equipment said Q1 revenue will fall 24% from a year earlier to $465 million, compared with the consensus estimate of $536 million as measured by Capital IQ.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: HALO , ISRG

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by